We demonstrated that both the T6211M nesprin-2 mutation identified in patients with EDMD and DCM and the R153H telethonin mutation identified in an HCM patient significantly altered the interaction between nesprin-2 and telethonin. The gene discussed is TCAP; the disease is Emery-Dreifuss muscular dystrophy.